Vivek Pradhan
Pfizer (United States)(US)
Publications by Year
Research Areas
Statistical Methods and Bayesian Inference, Inflammatory Bowel Disease, Statistical Methods in Clinical Trials, Advanced Statistical Methods and Models, Statistical Methods and Inference
Most-Cited Works
- → Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial(2017)197 cited
- → Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study(2022)61 cited
- → Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled study(2022)52 cited
- → Choice of test for association in small sample unordered r × c tables(2007)46 cited
- → A comparative study of the bias corrected estimates in logistic regression(2008)44 cited
- → Small-sample comparisons of confidence intervals for the difference of two independent binomial proportions(2006)35 cited
- → Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group study(2020)32 cited
- → Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study(2023)29 cited
- → Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects(2016)29 cited
- → Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn’s Disease: Report of the TOSCA Study(2017)28 cited